MedPath

Jetema Co., Ltd.

Jetema Co., Ltd. logo
🇰🇷South Korea
Ownership
Public
Established
2009-07-17
Employees
232
Market Cap
-
Website
http://www.jetema.com

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

A Clinical Study to Evaluate the Efficacy and Safety of the Injection With UNIVELO Sub-Q, as Compared to Restylane® Sub-Q, in the Temporary Correction of the Nasolabial Fold

Not Applicable
Completed
Conditions
Nasolabial Fold
First Posted Date
2025-09-02
Last Posted Date
2025-09-08
Lead Sponsor
Jetema Co., Ltd.
Target Recruit Count
65
Registration Number
NCT07150273

Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S

Completed
Conditions
Nasolabial Folds
Mid Face Volume Loss
Lip Volume Enhancement
First Posted Date
2024-11-21
Last Posted Date
2024-11-21
Lead Sponsor
Jetema Co., Ltd.
Target Recruit Count
238
Registration Number
NCT06699147
Locations
🇰🇷

Clinics, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.